EHRA Premium Access

Controversies in ventricular tachycardia (VT) ablation

Event: EHRA 2022
Topic: Catheter Ablation of Arrhythmias
Session type: Debate Session
Date: 4 April 2022
Time: 09:40 - 10:40

Congress Session

6 presentations in this session

What will improve the results of VT ablation? Better mapping.

Speaker: Doctor P. Maury (Toulouse, FR)
Thumbnail

What will improve the results of VT ablation? Better technology.

Speaker: Professor J. Kautzner (Prague, CZ)
Thumbnail

What will improve the results of VT ablation? - rebuttal and discussion.

Thumbnail

Preferred first-line therapy for recurrent implantable cardioverter defibrillator shocks: drugs?

Speaker: Professor A. Goette (Paderborn, DE)
Thumbnail

Preferred first-line therapy for recurrent implantable cardioverter defibrillator shocks: ablation?

Speaker: Doctor M. Saba (London, GB)
Thumbnail

Preferred first-line therapy for recurrent implantable cardioverter defibrillator shocks - rebuttal and discussion.

Thumbnail

4 speakers from this session

Doctor Philippe Maury

Rangueil Hospital of Toulouse, Toulouse (France)
7 presentations
0 follower

Professor Josef Kautzner

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)
27 presentations
3 followers

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)
31 presentations
0 follower

Doctor Magdi Saba

St George's University Hospital NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
5 presentations
0 follower

Related content

ESC Premium Access

Regional Clinical Trials

4 December 2021

ESC Premium Access

Trials Focus: APAF-CRT / ACST-2

4 December 2021

This platform is supported by

logo Novo Nordisk